Oxcarbazepine adjunctive therapy in infants and young children with partial seizures

Authors:
  • RER. Espinoza
    R. Espinoza
  • DND. Nordli
    D. Nordli
  • DBD. A. Bennett
    D. A. Bennett
  • SSS. Spirito
    S. Spirito
  • TST. E. Stites
    T. E. Stites
  • DTD. Tang
    D. Tang
  • YSY. Sturm
    Y. Sturm

Abstract
Objective: To evaluate the efficacy, safety, and pharmacokinetics of oxcarbazepine as adjunctive therapy in infants and young children (1 month to p = 0.043). The median percentage reduction in type 1 seizure frequency per 24 hours was also greater in the high-dose group (83.33%) than in the low-dose group (46.18%; p = 0.047). The most frequent adverse events (≥10%) were somnolence and pyrexia, and most were mild in severity. Conclusions: In this study, high-dose oxcarbazepine was significantly more effective than low-dose oxcarbazepine in controlling partial seizures in infants and very young children.